Delivery Order SPE2DB24D2216-SPE2DB25FGNCS
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$6.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,127.36 firm fixed-price delivery order is for the supply of 4,567,461,943 units of Pantoprazole Sodium Delayed-Release 40 mg tablets, a medication used for the treatment of various gastrointestinal conditions. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,420.47, is a delivery order for the supply of 4,566,964,601 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has an ultimate completion date of January 17, 2025, and uses a firm-fixed-price pricing structure. The contract is not designated as a set-aside....
This federal contract award, valued at $5,637.03, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of 4,564,977,390 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a completion date of June 24, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical to...
This federal contract award is for the delivery of 4,564,731,258 units of pantoprazole sodium delayed-release 40 mg tablets in 1,000 count sizes. The contract was awarded to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,833.54. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside...
This federal contract award, valued at $1,032.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that provides Pantoprazole Sodium Delayed-Release 20 mg Tablets in quantities of 90s. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $5,872.98, is for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets in 1,000-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of February 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,554,560,733 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000 count bottles. The $5,544.87 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,106.30 contract is for the delivery of 4,565,925,866 units of the drug Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of September 25, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several Indefinite...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FQE54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,132.94, is for the delivery of 4,564,451,658 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets 1000s. This is a Firm Fixed Price delivery order contract with a completion date of May 1, 2024. The contract does not have a set-aside designation,...
This federal contract award, with ID SPE2DB20D1004|SPE2DB23FF0H6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,111.76 firm fixed price delivery order is for the supply of 4,559,476,715 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999...